Used in vaccine development and diagnostic assays to detect neutralizing antibodies against the Omicron BA.4 variant of SARS-CoV-2. Serves as a key antigen in serological testing to evaluate immune response in infected or vaccinated individuals. Employed in research studies focusing on viral entry mechanisms and antibody binding affinity. Facilitates the screening and development of therapeutic monoclonal antibodies targeting the spike protein’s receptor-binding domain.